US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist

0.000
0.0000.00%

Trading Jul 11 09:30 ET

0Market Cap0.00P/E (TTM)

Actuate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

--2.07M

-85.53%2.96M

--20.45M

-Cash and cash equivalents

--2.07M

-85.53%2.96M

--20.45M

Other current assets

--119.77K

9.37%36.91K

--33.75K

Total current assets

--2.19M

-85.38%3M

--20.48M

Non current assets

Non current deferred assets

--510.5K

----

----

Total non current assets

--510.5K

--0

--0

Total assets

--2.7M

-85.38%3M

--20.48M

Liabilities

Current liabilities

Payables

--3.96M

60.59%3.42M

--2.13M

-accounts payable

--3.96M

60.59%3.42M

--2.13M

Current accrued expenses

--5.5M

54.71%3.22M

--2.08M

Current debt and capital lease obligation

--5M

----

----

-Current debt

--5M

----

----

Current liabilities

--14.73M

59.28%6.92M

--4.34M

Non current liabilities

Non current accrued expenses

--135.12K

50.51%130.04K

--86.4K

Derivative product liabilities

--1.02M

21.33%988.05K

--814.36K

Preferred securities outside stock equity

--94.18M

4.48%94.18M

--90.14M

Total non current liabilities

--95.74M

4.66%95.7M

--91.44M

Total liabilities

--110.47M

7.13%102.62M

--95.79M

Shareholders'equity

Share capital

--2

0.00%2

--2

-common stock

--2

0.00%2

--2

Retained earnings

---113.39M

-30.80%-105.09M

---80.35M

Paid-in capital

--5.62M

8.40%5.47M

--5.04M

Total stockholders'equity

---107.77M

-32.30%-99.63M

---75.31M

Total equity

---107.77M

-32.30%-99.63M

---75.31M

Currency Unit

USD

USD

USD

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	--2.07M	-85.53%2.96M	--20.45M
-Cash and cash equivalents	--2.07M	-85.53%2.96M	--20.45M
Other current assets	--119.77K	9.37%36.91K	--33.75K
Total current assets	--2.19M	-85.38%3M	--20.48M
Non current assets
Non current deferred assets	--510.5K	----	----
Total non current assets	--510.5K	--0	--0
Total assets	--2.7M	-85.38%3M	--20.48M
Liabilities
Current liabilities
Payables	--3.96M	60.59%3.42M	--2.13M
-accounts payable	--3.96M	60.59%3.42M	--2.13M
Current accrued expenses	--5.5M	54.71%3.22M	--2.08M
Current debt and capital lease obligation	--5M	----	----
-Current debt	--5M	----	----
Current liabilities	--14.73M	59.28%6.92M	--4.34M
Non current liabilities
Non current accrued expenses	--135.12K	50.51%130.04K	--86.4K
Derivative product liabilities	--1.02M	21.33%988.05K	--814.36K
Preferred securities outside stock equity	--94.18M	4.48%94.18M	--90.14M
Total non current liabilities	--95.74M	4.66%95.7M	--91.44M
Total liabilities	--110.47M	7.13%102.62M	--95.79M
Shareholders'equity
Share capital	--2	0.00%2	--2
-common stock	--2	0.00%2	--2
Retained earnings	---113.39M	-30.80%-105.09M	---80.35M
Paid-in capital	--5.62M	8.40%5.47M	--5.04M
Total stockholders'equity	---107.77M	-32.30%-99.63M	---75.31M
Total equity	---107.77M	-32.30%-99.63M	---75.31M
Currency Unit	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall